Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Topical cycloheximide in psoriasis

L F Montes

    Journal of Cutaneous Pathology
    |January 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Cycloheximide, an inhibitor of DNA and protein synthesis, effectively reduced psoriatic plaques when applied topically at low concentrations. Further safety evaluations are ongoing for this potent experimental drug.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Development of vitiligo in children following separation of parents.

    Clinical and experimental dermatology·2008
    Same author

    Cycloheximide in dermatology.

    Acta dermato-venereologica·1997
    Same author

    Gigantic ichthyosis hystrix.

    Journal of the American Academy of Dermatology·1997
    Same author

    Response of leiomyosarcoma to cryosurgery: clinicopathological and ultrastructural study.

    Clinical and experimental dermatology·1995
    Same author

    Folic acid and vitamin B12 in vitiligo: a nutritional approach.

    Cutis·1992
    Same author

    Topical griseofulvin in tinea versicolor: a double-blind study.

    Journal of the American Academy of Dermatology·1991
    Same journal

    Diagnostic Challenge of a White Plaque on the Gingiva: Case Report of Glycogenic Acanthosis.

    Journal of cutaneous pathology·2026
    Same journal

    Elevated IL-4 and IL-13 Expression in Hailey-Hailey Disease: Evidence for Th2-Mediated Pathogenesis and Targeted Treatment.

    Journal of cutaneous pathology·2026
    Same journal

    Blastic Plasmacytoid Dendritic Cell Neoplasm.

    Journal of cutaneous pathology·2026
    Same journal

    Atypical Grover Disease Associated With Merkel Cell Carcinoma: A Novel Paraneoplastic Presentation.

    Journal of cutaneous pathology·2026
    Same journal

    Profile of a Founder: Herbert Zachareus Lund.

    Journal of cutaneous pathology·2026
    Same journal

    The National Resident Match Program Arrives in Dermatopathology: 15 Years of Resilient Advocacy by the American Society of Dermatopathology's Fellowship Training Program Directors' Committee.

    Journal of cutaneous pathology·2026
    See all related articles

    Area of Science:

    • Dermatology
    • Pharmacology
    • Cell Biology

    Background:

    • Psoriasis is a chronic inflammatory skin condition.
    • Cycloheximide is known to inhibit DNA and protein synthesis.
    • Antimitotic agents are explored for dermatological applications.

    Purpose of the Study:

    • To evaluate the efficacy of topical Cycloheximide in treating psoriatic plaques.
    • To assess the potential of Cycloheximide as a therapeutic agent for psoriasis.

    Main Methods:

    • Topical application of Cycloheximide at low concentrations (0.1%-0.2%) on psoriatic plaques.
    • Observation of plaque involution.
    • Cautionary use due to drug potency.

    Main Results:

    Related Experiment Videos

    • Definite involution of psoriatic plaques was observed.
    • Low concentrations of Cycloheximide demonstrated efficacy.

    Conclusions:

    • Topical Cycloheximide shows promise in reducing psoriatic lesions.
    • The drug's potency necessitates careful application and further safety studies.